Pharmacy

The FDA has approved Skyrizi (risankizumab-rzaa), the first and only IL-23 inhibitor in the U.S., to treat children ages 6 years and older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, or active psoriatic arthritis. The…

University Hospitals Parma (Ohio) Medical Center has opened a UH Meds Retail Pharmacy that provides prescription services for patients, employees and the community. The pharmacy offers the health system’s Meds to Beds program, in which pharmacists deliver medications to hospitalized…

Becker’s is proud to spotlight chief pharmacy officers who ensure that the right medications reach the right patients at the right time.  They are tasked with overseeing complex supply chains, managing formularies at enormous scale, and standing as critical guardians…

Sen. Bill Cassidy, MD, R-La., has crafted a discussion draft of legislation that would overhaul the 340B Drug Pricing Program with new transparency, oversight and accountability requirements for covered entities. The draft, released June 25, proposes reforms intended to ensure…

Pharmacist job postings jumped 63% in the fourth quarter of 2025. Sterile-compounding technician vacancies hit 92% of hospitals. And clinical responsibilities keep expanding. The numbers behind pharmacy’s workforce crisis tell a consistent story: demand is outpacing supply — and the…

Becker’s asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share their focus areas for the remaining 6 months of the year. The 13 executives featured in this article are…

Maryland pharmacists will gain expanded authority to participate in opioid use disorder treatment under a new state law taking effect July 1. House Bill 838 eliminates the requirement that authorized prescribers submit prescriber-pharmacist agreements to the applicable health occupations board.…

Shortages of several generic chemotherapy drugs are straining hospital supply chains and raising concerns that cancer centers may need to ration treatment for some patients, according to a June 24 New York Times report. Manufacturing problems, shipping delays and decisions…

Four major hospital associations are calling on federal regulators to intervene after Eli Lilly followed through on its threat to cut off 340B drug pricing to hospitals that refused to comply with its in-house pharmacy claims reporting requirements. Eli Lilly…

The FDA has changed its position on two separate therapies in recent weeks, allowing a melanoma treatment and a Huntington’s disease gene therapy to advance toward approval after earlier rejections. Replimune reached an agreement with the FDA on a path…